Immediate Impact
2 from Science/Nature 49 standout
Citing Papers
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Autophagy in cancer development, immune evasion, and drug resistance
2024 Standout
Works of Gerald Post being referenced
Single‐agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas
2011
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gerald Post | 624 | 261 | 211 | 40 | 908 | |
| K. Hahn | 505 | 278 | 180 | 43 | 877 | |
| Wallace B. Morrison | 680 | 218 | 277 | 40 | 1.1k | |
| Gerry Polton | 780 | 313 | 155 | 57 | 1.0k | |
| John M. Gliatto | 736 | 407 | 292 | 30 | 1.0k | |
| Kristine Burgess | 713 | 322 | 260 | 40 | 1.1k | |
| R. S. Brodey | 680 | 302 | 238 | 32 | 1.1k | |
| Glenna E. Mauldin | 598 | 324 | 228 | 44 | 1.0k | |
| Tracy L. Gieger | 882 | 468 | 191 | 69 | 1.1k | |
| Michelle Turek | 771 | 336 | 204 | 45 | 1.2k | |
| Silvia Sabattini | 1004 | 607 | 216 | 83 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...